AAAAAA
Results: 1-25/44
Authors:
Lind, K
Kresse, M
Muller, RH
Citation: K. Lind et al., Evaluation of desorption of proteins adsorbed to hydrophilic surfaces by two-dimensional electrophoresis, PROTEOMICS, 1(9), 2001, pp. 1059-1066
Authors:
Muller, RH
Kleinsteuber, S
Babel, W
Citation: Rh. Muller et al., Physiological and genetic characteristics of two bacterial strains utilizing phenoxypropionate and phenoxyacetate herbicides, MICROBI RES, 156(2), 2001, pp. 121-131
Authors:
Krause, KP
Muller, RH
Citation: Kp. Krause et Rh. Muller, Production of aqueous shellac dispersions by high pressure homogenisation, INT J PHARM, 223(1-2), 2001, pp. 89-92
Authors:
Scholer, N
Olbrich, C
Tabatt, K
Muller, RH
Hahn, H
Liesenfeld, O
Citation: N. Scholer et al., Surfactant, but not the size of solid lipid nanoparticles (SLN) influencesviability and cytokine production of macrophages, INT J PHARM, 221(1-2), 2001, pp. 57-67
Authors:
Jacobs, C
Kayser, O
Muller, RH
Citation: C. Jacobs et al., Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone, INT J PHARM, 214(1-2), 2001, pp. 3-7
Authors:
Lippacher, A
Muller, RH
Mader, K
Citation: A. Lippacher et al., Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles, INT J PHARM, 214(1-2), 2001, pp. 9-12
Authors:
Krause, KP
Muller, RH
Citation: Kp. Krause et Rh. Muller, Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation, INT J PHARM, 214(1-2), 2001, pp. 21-24
Authors:
Gessner, A
Olbrich, C
Schroder, W
Kayser, O
Muller, RH
Citation: A. Gessner et al., The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles, INT J PHARM, 214(1-2), 2001, pp. 87-91
Authors:
Demirel, M
Yazan, Y
Muller, RH
Kilic, F
Bozan, B
Citation: M. Demirel et al., Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles, J MICROENC, 18(3), 2001, pp. 359-371
Authors:
Lind, K
Kresse, M
Muller, RH
Citation: K. Lind et al., Comparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivo, ELECTROPHOR, 22(16), 2001, pp. 3514-3521
Authors:
Muller, RH
Jacobs, C
Kayser, O
Citation: Rh. Muller et al., Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future, ADV DRUG DE, 47(1), 2001, pp. 3-19
Authors:
Hoffmann, D
Kleinsteuber, S
Muller, RH
Babel, W
Citation: D. Hoffmann et al., Development and application of PCR primers for the detection of the tfd genes in Delftia acidovorans P4a involved in the degradation of 2,4-D, ACT BIOTECH, 21(4), 2001, pp. 321-331
Authors:
Muller, RH
Babel, W
Citation: Rh. Muller et W. Babel, Pseudo-recalcitrance of chlorophenoxyalkanoate herbicides - Correlation tothe availability of alpha-ketoglutarate, ACT BIOTECH, 21(3), 2001, pp. 227-242
Authors:
Scholer, N
Krause, K
Kayser, O
Muller, RH
Borner, K
Hahn, H
Liesenfeld, O
Citation: N. Scholer et al., Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis, ANTIM AG CH, 45(6), 2001, pp. 1771-1779
Authors:
Wissing, SA
Muller, RH
Citation: Sa. Wissing et Rh. Muller, Solid lipid nanoparticles (SLN) - a novel carrier for UV blockers, PHARMAZIE, 56(10), 2001, pp. 783-786
Authors:
Rudolph, C
Lausier, J
Naundorf, S
Muller, RH
Rosenecker, J
Citation: C. Rudolph et al., In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers, J GENE MED, 2(4), 2000, pp. 269-278
Authors:
Grau, MJ
Kayser, O
Muller, RH
Citation: Mj. Grau et al., Nanosuspensions of poorly soluble drugs - reproducibility of small scale production, INT J PHARM, 196(2), 2000, pp. 155-159
Authors:
Jacobs, C
Kayser, O
Muller, RH
Citation: C. Jacobs et al., Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide, INT J PHARM, 196(2), 2000, pp. 161-164
Authors:
Krause, KP
Kayser, O
Mader, K
Gust, R
Muller, RH
Citation: Kp. Krause et al., Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation, INT J PHARM, 196(2), 2000, pp. 169-172
Authors:
Liedtke, S
Wissing, S
Muller, RH
Mader, K
Citation: S. Liedtke et al., Influence of high pressure homogenisation equipment on nanodispersions characteristics, INT J PHARM, 196(2), 2000, pp. 183-185
Authors:
Zimmermann, E
Muller, RH
Mader, K
Citation: E. Zimmermann et al., Influence of different parameters on reconstitution of lyophilized SLN, INT J PHARM, 196(2), 2000, pp. 211-213
Authors:
Lippacher, A
Muller, RH
Mader, K
Citation: A. Lippacher et al., Investigation on the viscoelastic properties of lipid based colloidal drugcarriers, INT J PHARM, 196(2), 2000, pp. 227-230
Authors:
Seehof, K
Kresse, M
Mader, K
Muller, RH
Citation: K. Seehof et al., Interactions of nanoparticles with body proteins - improvement of 2D-PAGE-analysis by internal standard, INT J PHARM, 196(2), 2000, pp. 231-234
Authors:
Scholer, N
Zimmermann, E
Katzfey, U
Hahn, H
Muller, RH
Liesenfeld, O
Citation: N. Scholer et al., Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages, INT J PHARM, 196(2), 2000, pp. 235-239
Authors:
Gessner, A
Waicz, R
Lieske, A
Paulke, BR
Mader, K
Muller, RH
Citation: A. Gessner et al., Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption, INT J PHARM, 196(2), 2000, pp. 245-249